Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Development of NSAIDs with reduced gastrointestinal and renal toxicity
- 1 July 1995
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 4 (7), 613-619
- https://doi.org/10.1517/13543784.4.7.613
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Detection of cyclooxygenase-1 and -2 proteins and mRNA in gastric ulcerPathophysiology, 1994
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- A diclofenac derivative without ulcerogenic propertiesEuropean Journal of Pharmacology, 1994
- Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.JCI Insight, 1994
- Effects of Transforming Growth Factor β and Interleukin-1β on Expression of Cyclooxygenase 1 and 2 and Phospholipase A2 mRNA in Lung Fibroblasts and Endothelial Cells in CultureBiochemical and Biophysical Research Communications, 1993
- Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proceedings of the National Academy of Sciences, 1993
- Interleukin-1 Differentially Modulates Chondrocyte Expression of Cyclooxygenase-2 and Phospholipase A2Experimental Cell Research, 1993
- Gastric ulceration: critical events at the neutrophil–endothelium interfaceCanadian Journal of Physiology and Pharmacology, 1993
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- Focal gastric mucosal blood flow at the site of aspirin-induced ulcerationThe American Journal of Surgery, 1985